University of Miami School of Medicine, Miami, FL
American College of Endocrinology
Paul S. Jellinger, MD, MACE, is Professor of Medicine on the voluntary faculty at the University of Miami, Florida. After receiving his medical degree from Wayne State University School of Medicine, he completed a first-year medical residency at Beth Israel Hospital and a second-year residency at Mount Sinai Hospital in New York City. Dr. Jellinger subsequently was awarded an NIH fellowship in Endocrinology at Mount Sinai Hospital. He has served as Chief of the Section of Endocrinology at Memorial Regional Hospital in Hollywood, Florida. Dr. Jellinger is also Immediate Past President of the American College of Endocrinology (ACE) and is a Past President of the American Association of Clinical Endocrinologists (AACE). In 2004, he became a Master of the ACE. Dr. Jellinger is involved in many regional and national professional and scientific associations including the Endocrine Society and American Diabetes Association, and is Past President of the Florida Endocrine Society. He is board-certified in internal medicine and endocrinology and metabolism. He has also conducted investigative research on over 50 subjects and is currently conducting research for several major pharmaceutical companies. He now serves as medical editor of Clinical Endocrinology News. Dr. Jellinger, who was a founding member, was elected President of the AACE, a 5,500 physician member organization, in 2000. He has been active on the AACE Board of Directors and has served as chairman of several committees including the Clinical Research Committee. Dr. Jellinger was also a member of the task forces that defined and published the AACE Guidelines for the Management of Diabetes Mellitus, the Evaluation and Treatment of Hyperthyroidism and Hypothyroidism and the Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. He served as Chairman of the Task Force for the published AACE Guidelines on the Treatment of Lipid Disorders in the Prevention of Atherogenesis. Dr. Jellinger was a participant in the 2001 and 2002 ACE/AACE Consensus Conferences on Glycemic Control and the Insulin Resistance Syndrome and was co-chairman of the recent ACE/AACE Diabetes Consensus Conference on Implementation of Glycemic Goals. He lectures frequently on topics related to diabetes mellitus and lipid disorders.
You need to be logged in to save this episode to a playlist.